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Electrospun scaffolds provide a dense framework of nanofibers with pore sizes and fiber diameters that closely resemble the
architecture of native extracellular matrix. However, it generates limited three-dimensional structures of relevant physiological
thicknesses. 3D printing allows digitally controlled fabrication of three-dimensional single/multimaterial constructs with precisely
ordered fiber and pore architecture in a single build. However, this approach generally lacks the ability to achieve submicron
resolution features to mimic native tissue. The goal of this study was to fabricate and evaluate 3D printed, electrospun, and
combination of 3D printed/electrospun scaffolds to mimic the native architecture of heterogeneous tissue. We assessed their
ability to support viability and proliferation of human adipose derived stem cells (hASC). Cells had increased proliferation
and high viability over 21 days on all scaffolds. We further tested implantation of stacked-electrospun scaffold versus combined
electrospun/3D scaffold on a cadaveric pig knee model and found that stacked-electrospun scaffold easily delaminated during
implantation while the combined scaffold was easier to implant. Our approach combining these two commonly used scaffold
fabrication technologies allows for the creation of a scaffold with more close resemblance to heterogeneous tissue architecture,
holding great potential for tissue engineering and regenerative medicine applications of osteochondral tissue and other
heterogeneous tissues.
1. Introduction
Tissue engineering is a growing field that aims to create
living biological substitutes to restore, repair, or regenerate
native tissue or organ function that may be affected by
disease or injury.Themain components of engineered tissues
include cells, scaffolds, and chemical and/or mechanical cues
to replicate or mimic the physiological conditions of the
target tissue [1].The individual characteristics of each of these
components and their interactions have a significant impact
on the quality and functionality of engineered tissues [2]. As
such, it is important to determine the optimum combination
of relevant characteristics for any target tissue to be engi-
neered.
Themost commonly used strategies in tissue engineering
involve seeding a uniform or homogenous scaffold with a
single cell type. But, in reality, most tissues are composed of
several cell types and a diverse and heterogenic extracellular
matrix (ECM) framework [3, 4]. Failure to replicate the phys-
iological and native conditions can have negative results in
engineered tissue integration and function when implanted
in an organism [1, 5]. Scaffold design in tissue engineering
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is particularly important, as the scaffold should not only
provide an optimal 3D network to support cell adhesion and
proliferation but also appropriately guide cell differentiation,
when stem cells are used, to generate the desired tissue(s)
[6, 7]. Osteochondral tissue engineering has proven to be
very complex due to the presence of different cell types, ECM
heterogeneity, and the multiple three-dimensional materials
which characterize an articular joint including the following:
porous subchondral bone, a transitional dense cartilage
framework, and a tidemark separating the layers [4, 8]. Most
scaffold fabrication techniques cannot recapitulate the het-
erogeneous multiphasic porous architecture that is native to
an articular joint.
The goal of this studywas to combine two commonly used
fabrication techniques—electrospinning and 3Dprinting—to
develop a simple and reproducible scaffold that incorporates
both nano- and microscale fibrous architecture and more
closelymimic heterogenous tissues.We evaluated a combined
3D printed/electrospun scaffold architecture mimicking het-
erogeneous tissues such as the osteochondral complex, in
comparison to solely 3D printed microfibrous or solely elec-
trospun nanofibrous scaffolds, for their ability to support via-
bility and proliferation of human adipose-derived stem cells
(hASC). Further, we also tested and compared the feasibility
and efficacy of implanting full-thickness (6mm) combined
3D printed/electrospun versus stacked electrospun scaffolds
in an ex vivo porcine model using a clinically relevant pro-
cedure for osteochondral defect repair. The results show the
ability to successfully engineer a scaffold that resembles the
physiological thickness as well as a multiscale heterogeneous
fibrous architecture of osteochondral tissue. This combined
3D printing/electrospinning approach could be extended to
other tissues with heterogenous ECM framework and/or
transitional tissues like ligament and tendon bone insertions
in the future.
2. Materials and Methods
2.1. 3D-Bioplotting Microfibrous Scaffolds. Thin disc-shaped
scaffolds (Ø 14.5mm × 2mm) (Figure 1(a)) were fabricated
using polycaprolactone (PCL, 𝑀
𝑊
= 80K, Sigma-Aldrich
Co., St. Louis, MO) on a 3D-Bioplotter (4th-Generation
Developer Series, EnvisionTEC GmbH, Gladbeck, Ger-
many). The scaffolds and their CAD model (Solidworks
2014) were designed to facilitate the fitting and culturing of
finished constructs in standard 24-well cell culture plates.
Previously determined optimal bioplotting process param-
eters were used [9–11]. In brief, PCL was extruded at an
extrusion pressure of 0.5N/mm2 and extrusion temperature
of 180∘C through a 0.4mm inner diameter nozzle with a
printing speed of 0.4mm/s following a 45-minute preheat
interval for stabilization and air removal from the melt. The
scaffold design featured a separation of 1.5mm between the
axes of adjacent strands, which kept constant through all
the layers, and a strand lay-down pattern of 0∘/120∘/240∘
between adjacent layers, yielding a highly interconnected
pore network.
2.2. ElectrospinningNanofibrous Scaffolds. PCLwas dissolved
in chloroform and dimethylformamide (Sigma) at a ratio of
3 : 1 to create an 11% solution. The solution was mixed con-
tinuously at 80∘C for at least 4 hours. The PCL solution was
electrospun using an internal nozzle diameter of 0.508mm
on a static collector covered with aluminum for 3 hours
immediately after preparation at a feed rate of 0.7 𝜇L/hr and
spinning distance of 13–15 cm using 15 kV. The electrospun
nanofibrous scaffolds were detached from the aluminum
surface prior to being used.
Stacked scaffolds (6mm thick) used for implantation
were generated by stacking together multiple electrospun
layers using collagen type I gel in between the layers, at a
concentration of 3mg/mL (Vitrogen, Angiotech BioMaterials
Corporation, Palo Alto, CA) [12]. Collagen was first neutral-
ized to pH 7.0, pipetted between the layers, and allowed to
polymerize for 2 hours at 37∘C.
2.3. Combined 3D-BioplottedMicrofibrous/ElectrospunNanofi-
brous Scaffolds. The integrated micro- and nanofibrous PCL
scaffolds were fabricated using a combination of 3D-bio-
plotting and electrospinning.The electrospun layers were cut
into 14.5mm diameter circles to match the size of the 3D
scaffolds. First, a 2mmbasal section of 3D-bioplotted scaffold
was printed as mentioned above. We then placed the circular
electrospun layer directly over the basal layer and continued
printing another 2mm section on top of the electrospun layer
to generate a final 4mm thick scaffold with an electrospun
layer in the middle (Figure 1). These scaffolds were used for
testing hASC viability and proliferation. The full thickness
(6mm) scaffolds evaluated for implantation techniques were
fabricated using the same procedure but with 4mm basal
section and 2mm top section 3D bioplotted.
2.4. Isolation and Expansion of Human Adipose-Derived Stem
Cells. Excess adipose tissue was collected from five female
premenopausal donors (ages 24 to 36) in accordance with
an approved IRB protocol at UNC Chapel Hill (IRB 04-
1622) [13]. Human ASC were isolated from the tissue as
previously described by our lab and others [14–16]. Cells
were expanded in complete growth medium (CGM) com-
prised of alpha-modified minimal essential medium (𝛼-
MEM with L-glutamine) (Invitrogen, Carlsbad CA), 10%
fetal bovine serum (FBS) (Premium Select, Atlanta Biologi-
cals, Lawrenceville GA), 200mM L-glutamine, and 100 I.U.
penicillin/100 𝜇g/mL streptomycin (Mediatech, Herndon
VA).The cells were cultured at 37∘C in 5%CO
2
until reaching
80% confluency and then passaged using trypsin-EDTA
(Invitrogen). A superlot was generated by pooling equal
numbers of cells from the five individual donor cell lines
into a single culture vessel and characterized for multilineage
differentiation potential, ensuring the cells differentiated
representative of an average of the five cell lines [13].
2.5. Seeding of Scaffolds. The 3D-bioplotted, electrospun, and
combined bioplotted/electrospun disc scaffolds (Ø 14.5mm)
were designed and fabricated to fit in 24-well plates (well Ø
15.6mm), limiting any space between the walls of the well
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Figure 1: Fabrication of combined micro- and nanofibrous scaffold by sandwiching an electrospun layer between 3D-bioplotted layers. (a)
Schematic of technical approach. (b) 3D-bioplotted scaffold with and without an electrospun layer (scale bars top = 2mm; bottom = 500𝜇m).
(c) Cross-sectional CAD representation of three different scaffolds created and evaluated. Top: microfibrous scaffold fabricated using 3D
bioplotting technique only. Middle: nanofibrous scaffold fabricated using electrospinning only. Bottom: alternating micro- and nanosized
fibers by combining 3D bioplotting and electrospinning techniques. Colors and textures for visualization purposes only.
and the periphery of the scaffold where cells could potentially
migrate towards the bottom of the wells. Prior to seeding,
scaffolds were sterilized for 30minutes in 70% ethanol, rinsed
three times with sterile phosphate buffered saline (PBS) and
once with CGM. Due to the difference in thickness between
the scaffold designs (electrospun = 200𝜇m, 3D-bioplotted =
2mm, and combined scaffolds = 4.2mm,), a total of 100,000
cells were seeded in each 3D scaffold and 20,000 cells in each
electrospun scaffold over a two-day period. On the first day,
half of the total amount of cells (50,000 cells for 3D scaffolds
and 10,000 cells for electrospun scaffolds) were resuspended
in 1mL of CGM and added to each well containing a scaffold.
The cells/scaffolds were incubated overnight while gently
rocking to allow cell distribution and adhesion throughout
the scaffolds.On the second day, each scaffoldwas overturned
and seeded with the remaining cells to allow adhesion of cells
4 BioMed Research International
on both sides of the scaffolds. Once again, the scaffolds were
incubated overnight while gently rocking. The scaffolds were
then transferred to a new well for performance of all assays.
2.6. Cell Viability Analyses. Seeded scaffolds were cultured
in CGM for 21 days to promote growth and proliferation.
After 21 days of culture, a LIVE/DEAD viability assay (Life
Technologies) was performed per themanufacturer’s instruc-
tions on all scaffolds to assess hASC viability within the
scaffolds. Briefly, hASC-seeded scaffolds were gently washed
with sterile PBS three times, and then 500𝜇L of 2 𝜇M calcein
AMand 4 𝜇MEthD-1 solutionwas added to each scaffold and
incubated for 30 minutes. Scaffolds were visualized using a
Leica DM5500B Fluorescent Microscope and the compatible
LAS-AF software. Two consecutive images per section were
taken to visualize live cells (green) and dead cells (red), and
a composite overlaid image was generated to visualize both
channels in the same frame. To optimize exposure, gain, and
intensity parameters, the LUT function of the software was
used. All images were taken at 10x magnification.
2.7. Cell Proliferation Analyses. Cell proliferation was assessed
(𝑛 = 4 scaffolds per time point) at days 1, 4, 7, 11, and 20
after seeding using the AlamarBlue colorimetric assay (Life
Technologies). Acellular scaffolds were also analyzed as
controls, and all data was normalized to the appropriate
acellular control scaffold. At each time point, a 1 : 10 ratio
of AlamarBlue : CGM solution was added to each scaffold
and incubated at 37∘C and 5% CO
2
for 3 hours. After incu-
bation, absorbance was measured at wavelengths of 570 nm
and 600 nm using a Microplate reader (Tecan Group Ltd.,
Ma¨nnedorf, Switzerland) and the Magellan Data Analysis
Software (Tecan Group Ltd.).
2.8. Implantation of Scaffolds in a Porcine Model. Cadaveric
porcine knees were utilized to create a suitable ex vivo
environment in a large animal model that resembles the
human knee.This model has been used extensively in vivo to
evaluate articular cartilage repair techniques [17, 18]. Using
current human surgical techniques and currently utilized
hardware (COR Osteochondral Autograft Transfer System,
DePuy Mitek, Raynham, MA), stacked electrospun scaffolds
and a single 3D-bioplotted scaffold were implanted into
osteochondral defects created via drilling to evaluate scaffold-
handling characteristics in the surgical setting. Osteochon-
dral Autograft Transfer techniques commonly employed for
human patients were utilized [19–21]. Briefly, a power reamer
was used to create an osteochondral defect to a depth of
8mm with an 8mm diameter. Using the donor cutting
tool from the COR system, an 8mm diameter section of
the osteochondral stacked scaffold was cut from a 14.5mm
diameter scaffold (typical size created using our approach).
The scaffold was then implanted into the recipient hole per
the recommended COR Osteochondral Autograft Transfer
System technique (DePuy Mitek, Raynham, MA), consistent
with current human surgical procedures. Optimal scaffold
depth was selected based on the handling ability of the
scaffold and successful implantation of the scaffolds to fill the
created defect.
2.9. Statistical Analysis. Statistical analysis was performed
using Prism (version 6.07, GraphPad Software). Bar graphs
are represented asmean± SEM.Differences were determined
using a one-way ANOVA with Tukey post hoc test. A level of
𝑝 < 0.05 was considered significant.
3. Results
3.1. Cell Viability, Migration, and Proliferation in Scaffolds.
Scanning electron microscopy (SEM) images show the dif-
ferent fiber size and arrangement between 3D-bioplotted and
electrospun scaffolds (Figures 2(a) and 2(b)), as well as the
combined nano/microfibrous scaffold (Figure 2(c)). Cells can
also be observed on the surface of all three seeded scaffolds
(Figures 2(d)–2(f)).
To ensure cells could grow and proliferate throughout in-
dividual nano- and microfibrous scaffolds, we first measured
and compared hASC proliferation and viability after 21 days
in culture in both electrospun and 3D-bioplotted scaffolds.
Cells were able to adhere and proliferate in both micro- and
nanofibrous scaffolds, with minimal dead cells observed after
21 days in culture.However, the hASC exhibited higher prolif-
eration and more uniform spreading in electrospun scaffolds
when compared to 3D-bioplotted scaffolds (Figure 3).
We then compared cell proliferation and migration in all
three scaffolds (Figure 4). Cells were visible on the superficial
layers of all three scaffolds (Figure 4(a)) and throughout
the scaffolds (Figure 4(b)). Cells seeded on 3D scaffolds
only had significantly increased proliferation after 14 days in
culture, with a decrease at day 21. Electrospun scaffolds had
significant increase in proliferation after 14 days in culture,
and the combined scaffold had a steady proliferation without
a decline over the 21-day culture period (Figure 4(c)).
3.2. Comparison of Implantation of Micro- and Nanofibrous
Scaffolds in a Porcine Ex Vivo Model. Standard human oper-
ative techniques were used to implant both stacked nanofi-
brous scaffolds and combination of 3D-bioplotted/electro-
spun scaffolds into a cadaveric porcine knee model, to de-
termine the translational applicability of these scaffolds in a
relevant in vivo model for osteochondral tissue engineering.
Due to the limited thickness of each electrospun layer
(approximately 200𝜇m), 30 different electrospun layers (each
Ø 14.5mm) were stacked using collagen I in between each
layer as previously described [22], to create a 6mm thick
scaffold. A 3D-bioplotted/electrospun scaffold (6mm thick;
14.5mm diameter) was also fabricated for implantation into
an osteochondral defect and to compare to the implantation
technique of the electrospun stacked scaffold. The COR
Osteochondral Autograft Transfer System technique was
compatible for sizing and implanting both stacked electro-
spun and 3D-bioplotted scaffolds. However, we found that
stacked electrospun scaffolds easily delaminated when using
the plug harvest system and needed to be frozen prior to
implantation to prevent delamination. The 3D-bioplotted
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Figure 2: Scanning electron microscopy of (a) 3D-bioplotted scaffold; (b) electrospun nanofibers; (c) combined 3D-bioplotted and
electrospun scaffolds (electrospun layer in middle); (d) cells growing on 3D-bioplotted scaffold; (e) cells growing on electrospun nanofibers;
and (f) cells growing on combined 3D and electrospun scaffold (scale bars (a), (c), (d) = 500 𝜇m; (b) = 100 𝜇m; (e) = 50 𝜇m; (f) = 1mm).
(a) (b)
(c) (d)
Figure 3: Cell viability and proliferation of human adipose-derived stem cells seeded on (a, c) 3D-bioplotted scaffolds and (b, d) electrospun
scaffolds (green = live cells; red = dead cells).
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Figure 4: Cell spreading and proliferation of human adipose-derived stem cells throughout scaffolds. Cells were cultured for 21 days in 3D-
bioplotted, electrospun, or combination of 3D-bioplotted/electrospun scaffolds, fixed, and stained (actin = red; nuclei = blue). Superficial and
cross-sectional views show cells present both on the surfaces of the scaffolds (superficial) and throughout the centers of the scaffolds on the
3D-bioplotted and combined scaffolds (cross-section). Human ASC exhibited steady proliferation over 21 days of culture on all scaffold types
as indicated by AlamarBlue (% AB reduction). Bars indicate mean ± SEM (∗∗∗𝑝 < 0.0001; ∗∗𝑝 < 0.005).
scaffolds and the combined 3D-bioplotted/electrospun scaf-
folds were easily inserted using the COR system and suc-
cessfully implanted into the cadaveric porcine knee without
delamination (Figure 5).
4. Discussion
Electrospinning is a commonly used technique in tissue
engineering allowing for production of a dense framework of
fibers with pore sizes and fiber diameters that closely resem-
ble the architecture of native ECM [23–25]. However, this
technique has limitations in generating three-dimensional
structures of relevant physiological thicknesses. 3D-printing
processes such as 3D-bioplotting have emerged in the last
decade as alternative techniques to generate scaffolds of phys-
iologically relevant thicknesses and morphologies that are
biomimetic to different tissues and organs [5, 26]. Although
these techniques have better three-dimensional geometrical
flexibility, they are limited to generation of microsized fibers
and larger pore sizes than those of electrospun scaffolds. Our
goal here was to develop amethodology to create amultiscale
scaffold design using a combination of electrospinning and
3D-bioplotting in order to better match the architecture of
heterogenous tissue, using osteochondral tissue as a sample
model.
Previous investigators have also attempted to combine
micro- and nanofibrous architecture into a single scaffold
for different tissue engineering applications. For example,
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Figure 5: Implantation technique of 3D-bioplotted, electrospun, and combined 3D-bioplotted/electrospun scaffolds into a cadaveric porcine
knee. (a) A power reamer was used to create an osteochondral defect to a depth of 8mm and 8mm diameter. (b) The COR system was
used to implant the scaffolds into the osteochondral defect. (c) View of 3D-bioplotted scaffold (left) and electrospun scaffold (right) after
implantation. (d) Combined 3D-bioplotted/electrospun scaffold prior to implantation (black arrows indicate electrospun layer, scale bar =
1mm). (e) Combined 3D-bioplotted/electrospun scaffold inserted into the COR system for implantation (bracket and arrow pointing at
scaffold inside the device). (f) Combined 3D-bioplotted/electrospun scaffold after implantation.
Yeo and Kim created cell-laden hierarchical scaffolds that
incorporated microsized fibers for support, combined with
electrospun nanofibers to enhance cell proliferation and
distribution [27]. Their approach incorporated cell-laden
alginate struts of osteoblast-like cells (MG63) to obtain
homogenous cell distribution within the scaffold. Although
they successfully achieved homogenous cell proliferation
throughout the scaffold, their complex fabrication procedure
required repetition of three different techniques includ-
ing melt-dispensing, followed by electrospinning, and cell-
dispensing in order to obtain cell-laden alginate struts. Their
goal was to create a homogenous tissue with even cell
distribution that could be used as a promising scaffold for
regeneration of soft and hard tissue, but not necessarily a
heterogenous tissue.
In this study, we present a facile and reproducible tech-
nique to develop an integrated approach combining both
electrospun nanofibers and 3D-plotted microfibers to reca-
pitulate the heterogenous architecture of native tissue. In
the first approach, we electrospun nanofibers over a 3D-
bioplotted scaffold. Although we successfully coated the
3D-bioplotted scaffold with electrospun nanofibers, the two
layers delaminated during culture of the combined micro/
nanofibrous scaffold in cell culturemedium (data not shown).
Such delamination would likely be a greater problem in vivo;
therefore we believe this technique is not appropriate for
generating a combined nano/microfibrous scaffold.
We therefore evaluated an alternative approach by 3D-
bioplotting directly on an electrospun scaffold. An electro-
spun nanofibrous layer was placed directly over a freshly
printed 3D scaffold, and then another 3D scaffold was
printed on top of this electrospun layer (Figure 1(a)). This
combined micro/nanofibrous scaffold did not delaminate
during culture. It is possible that the heat from the printed
microfibers facilitated binding of the nanofibers to the
printed microfibers; however, as observed in the SEM images
of the combined scaffold (Figure 2(c)), the heat did not
seem to impact the fiber morphology. Increased thickness
can be achieved by continued layering of the materials, alter-
nating between electrospun nanofibers and 3D-bioplotted
microfibers, to create a multilayered micro/nanofibrous scaf-
fold as needed. Based on our findings, the best approach
to fabricate a combined micro/nanofibrous scaffold was to
3D print over electrospun layers. This combined technique
produced single scaffolds that more closely resembled the
native heterogenous architecture.
Cell proliferation was significantly increased over time
in both 3D-bioplotted and electrospun scaffolds. Although
proliferation did not significantly increase over time in the
combined scaffolds, we still observed a steady proliferation
with no decline over time. Although cell proliferation and
viability were higher in the electrospun scaffolds, this tech-
nique has thickness and 3-dimensional limitations, typically
resulting in creation of a ∼200-micron scaffold after hours of
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electrospinning using conventional electrospinning systems.
In addition, stacking several electrospun layers to create a
thicker scaffold not only is time consuming but can also limit
themigration of cells throughout the layers (data not shown).
We first tested hASC cell viability and migration throughout
micro- and nanofibers by seeding cells on scaffolds with
either the electrospun layer on top or underneath the 3D-
bioplotted layer. We observed that when cells were seeded on
the 3D-bioplotted scaffold, the cells proliferated andmigrated
down to the electrospun layer. However, if the cells were
seeded over the electrospun layer, the nanofiber acted as a
barrier and prevented cells frommigrating down into the 3D-
bioplotted layer.
With our technique, the electrospun membrane can be
used to separate layers that require different cell types in
heterogenous tissues, like bone and cartilage in osteochon-
dral tissue. This way, the chondrocytes, for instance, will not
migrate into the underlying subchondral bone layer or vice
versa, while providing a natural framework that resembles the
tight collagen network in that area.
Ex vivo handling of 3D-bioplotted, stacked electrospun,
and combined 3D-bioplotted/electrospun constructs con-
firmed that they morphologically approximated the current
human tissue utilized for autologous osteochondral trans-
fer within human joints. Using clinically relevant surgical
techniques and commercially available hardware, acellular
scaffolds comprised of all three designs were successfully
implanted in situ using a porcine cadaveric knee. However,
the stacked electrospun nanofibrous scaffolds generated by
collagen binding of multiple single electrospun layers easily
delaminated when implanted in the porcine knee. These
stacked scaffolds needed to be frozen prior to implantation
in order to prevent delamination. This could be a critical
factor when dealing with seeded scaffolds and can affect cell
viability. The 3D-bioplotted and combined 3D-bioplotted/
electrospun scaffolds allowed for creation of clinically rele-
vant thicknesses (5–7mm) and were easily implanted using
standard surgical procedures without delamination or break-
age. This suggests a facile implementation of current auto-
graft human osteochondral techniques to implant such mul-
tiphasic osteochondral scaffolds, indicating the immediate
potential clinical translatability of our proposed combined
micro- and nanofibrous scaffolds.
5. Conclusion
Creation and utilization of appropriate scaffold architecture
are a critical step towards generation of an engineered tissue
construct that mimics complex native tissue. Electrospun
nanofibrous scaffolds, with their dense framework, pore sizes,
and fiber diameters, have limitations for creation of three-
dimensional structures of relevant physiological thicknesses.
We compared these nanofibrous scaffolds to 3D-bioplotted
scaffolds, constructs with better dimensional control and
reproducibility but thicker fibers and larger pore sizes. We
combined these two fabrication approaches, with results
indicating that a combination of 3D-bioplotted and electro-
spun scaffolds could provide an excellent alternative for full
heterogenous tissue regeneration. We tested our scaffolds
in a relevant implantation model for osteochondral tissue
and showed that although electrospun scaffolds yield higher
cell proliferation, they are hard to manipulate during a
clinically relevant osteochondral transplantation technique.
Our combined scaffold was easily implanted using common
surgical procedures into an osteochondral defect, without
delamination or breaking of the scaffold.
This is one of the first studies to combine two commonly
used scaffold fabrication technologies into a simple scaffold to
more closely match thicker tissues with heterogenous matrix
architecture. Such approaches may hold great potential for
tissue engineering and regenerative medicine applications.
Conflicts of Interest
The authors declare that there are no conflicts of interest
regarding the publication of this paper.
Acknowledgments
Special thanks are due to Saahil Mehendale for support on
scaffold design.Thisworkwas supported in part by theOrtho-
paedic Research and Education Foundation 15-059 (Jeffrey
Spang), NIH/NIBIB 1R03EB008790 (Elizabeth G. Loboa),
NIH/CTSA 550KR71418 (Elizabeth G. Loboa), NIH/CTSA
550KR61325 (Elizabeth G. Loboa), and NSF/CBET 1133427
(Elizabeth G. Loboa). The 3D-printing aspect of this study
was supported by a grant from NCSU Faculty Research
and Professional Development (FRPD) program (Rohan A.
Shirwaiker).
References
[1] Y. Ikada, “Challenges in tissue engineering,” Journal of the Royal
Society Interface, vol. 3, no. 10, pp. 589–601, 2006.
[2] R. L. Robert Lanza and J. P. Vacanti, “Principles of Tissue
Engineering,” 2013.
[3] A. Yousefi, M. E. Hoque, R. G. Prasad, and N. Uth, “Current
strategies in multiphasic scaffold design for osteochondral
tissue engineering: a review,” Journal of Biomedical Materials
Research Part A, vol. 103, no. 7, pp. 2460–2481, 2014.
[4] J. E. Jeon, C. Vaquette, T. J. Klein, and D. W. Hutmacher,
“Perspectives in multiphasic osteochondral tissue engineering,”
Anatomical Record, vol. 297, no. 1, pp. 26–35, 2014.
[5] M. Lee and B. M.Wu, “Recent advances in 3D printing of tissue
engineering scaffolds,” Methods in Molecular Biology, vol. 868,
pp. 257–267, 2012.
[6] S. J. Hollister, “Porous scaffold design for tissue engineering,”
Nature Materials, vol. 4, pp. 518–524, 2005.
[7] J. C. Bernhard and G. Vunjak-Novakovic, “Should we use cells,
biomaterials, or tissue engineering for cartilage regeneration?”
Stem Cell Research &Therapy, vol. 7, p. 56, 2016.
[8] S. P. Nukavarapu and D. L. Dorcemus, “Osteochondral tissue
engineering: current strategies and challenges,” Biotechnology
Advances, vol. 31, no. 5, pp. 706–721, 2013.
[9] C. Cai, P. Sheshadri, R. A. Shirwaiker, and E. G. Loboa, “Effect
of three dimensional polycaprolactone/hydroxyapatite scaffold
architecture on proliferation and osteogenesis of human adi-
pose derived stem cells,” in Proceedings of the TERMIS Americas
BioMed Research International 9
Annual Conference & Exposition, T. E. P. A, Ed., Washington,
DC, USA, 2014.
[10] L. F. Mellor, S. Mehendale, M. Mohiti-Asli et al., Evaluation of
Micro and Nano-Scale Scaffold Architectures for Osteochondral
Tissue Engineering, Orthopaedic Research Society, Las Vegas,
Nev, USA, 2015.
[11] S. V. Mehendale, L. F. Mellor, M. A. Taylor, E. G. Loboa, and R.
A. Shirwaiker, Rapid Prototyping Journal, vol. 23, 2017.
[12] S. D. McCullen, Y. Zhu, S. H. Bernacki et al., “Electrospun
composite poly(L-lactic acid)/tricalcium phosphate scaffolds
induce proliferation and osteogenic differentiation of human
adipose-derived stem cells,” Biomedical Materials, vol. 4, no. 3,
Article ID 035002, 2009.
[13] J. C. Bodle, S.D. Teeter, B.H.Hluck, J.W.Hardin, S.H. Bernacki,
and E. G. Loboa, “Age-related effects on the potency of human
adipose-derived stem cells: creation and evaluation of superlots
and implications for musculoskeletal tissue engineering appli-
cations,”Tissue Engineering—Part C:Methods, vol. 20, no. 12, pp.
972–983, 2014.
[14] P. A. Zuk, M. Zhu, H. Mizuno et al., “Multilineage cells from
human adipose tissue: implications for cell-based therapies,”
Tissue Engineering, vol. 7, no. 2, pp. 211–228, 2001.
[15] B. T. Estes, B. O. Diekman, J. M. Gimble, and F. Guilak, “Iso-
lation of adipose-derived stem cells and their induction to a
chondrogenic phenotype,” Nature Protocols, vol. 5, no. 7, pp.
1294–1311, 2010.
[16] S. H. Bernacki,M. E.Wall, and E. G. Loboa, “Isolation of human
mesenchymal stem cells frombone and adipose tissue,”Methods
in Cell Biology, vol. 86, pp. 257–278, 2008.
[17] G. Zhou, W. Liu, L. Cui, X. Wang, T. Liu, and Y. Cao, “Repair of
porcine articular osteochondral defects in non-weightbearing
areas with autologous bone marrow stromal cells,” Tissue
Engineering, vol. 12, no. 11, pp. 3209–3221, 2006.
[18] C. T. Lim, X. Ren, M. H. Afizah et al., “Repair of osteochondral
defectswith rehydrated freeze-dried oligo[poly(ethylene glycol)
fumarate] hydrogels seeded with bone marrow mesenchymal
stem cells in a porcine model,” Tissue Engineering—Part A, vol.
19, no. 15-16, pp. 1852–1861, 2013.
[19] V. Bobic, C. D. Morgan, and T. Carter, “Osteochondral autol-
ogous graft transfer,” Operative Techniques in Sports Medicine,
vol. 8, no. 2, pp. 168–178, 2000.
[20] C. L. Camp, M. J. Stuart, and A. J. Krych, “Current concepts
of articular cartilage restoration techniques in the knee,” Sports
Health, vol. 6, no. 3, pp. 265–273, 2014.
[21] A. Bedi, B. T. Feeley, and R. J. Williams III, “Management of
articular cartilage defects of the knee,”The Journal of Bone and
Joint Surgery Series A, vol. 92, no. 4, pp. 994–1009, 2010.
[22] L. F. Mellor, M. Mohiti-Asli, J. Williams et al., “Extracellular
calcium modulates chondrogenic and osteogenic differentia-
tion of human adipose-derived stem cells: a novel approach
for osteochondral tissue engineering using a single stem cell
source,” Tissue Engineering Part A, vol. 21, no. 17-18, pp. 2323–
2333, 2015.
[23] M. L. A. da Silva, A. Martins, A. R. Costa-Pinto et al., “Cartilage
tissue engineering using electrospunPCLnanofibermeshes and
MSCs,” Biomacromolecules, vol. 11, no. 12, pp. 3228–3236, 2010.
[24] W. Li, C. T. Laurencin, E. J. Caterson, R. S. Tuan, and F. K. Ko,
“Electrospun nanofibrous structure: a novel scaffold for tissue
engineering,” Journal of Biomedical Materials Research, vol. 60,
no. 4, pp. 613–621, 2002.
[25] W. J. Li, R. Tuli, C. Okafor et al., “A three-dimensional nanofi-
brous scaffold for cartilage tissue engineering using human
mesenchymal stem cells,” Biomaterials, vol. 26, no. 6, pp. 599–
609, 2005.
[26] S. V. Murphy and A. Atala, “3D bioprinting of tissues and
organs,” Nature Biotechnology, vol. 32, no. 8, pp. 773–785, 2014.
[27] M. Yeo and G. Kim, “Cell-printed hierarchical scaffolds con-
sisting of micro-sized polycaprolactone (PCL) and electrospun
PCL nanofibers/cell-laden alginate struts for tissue regenera-
tion,” Journal of Materials Chemistry B, vol. 2, pp. 314–324, 2014.
